Homburger acts as counsel to SIX Group in connection with the contemplated acquisition of Aquis Exchange, which was announced on November 11, 2024. SIX Group operates a fully integrated exchange value chain across the Swiss and Spanish
Tags :dx2
Homburger, on October 24, 2024, advised Avolta on a refinancing deal of its revolving credit facility (RCF). The amended EUR 2,400 m RCF with maturity in 2029 replaces the EUR 2,750 m RCF expiring in 2027. Avolta Avolta is a Swiss-based
Walder Wyss has advised 14Trees on the completion of an exclusive Series A-1 round backed by Amazon’s Climate Pledge Fund, alongside founding investor Holcim. The joint investment enables the rollout of 3D printing in
On September 23, 2024, UBS Switzerland, advised by Homburger and Walder Wyss, successfully completed its issuance of EUR 1 billion fixed rate covered bonds due September 23, 2027 under its covered bond programme. The Covered Bonds are governed by Swiss
Baker McKenzie acted for UBS Switzerland (“UBS”) as sole underwriter, mandated lead arranger, bookrunner, agent and security agent; and a group of Swiss and foreign lenders in connection with the amendment of ATP adhesive systems’
Niederer Kraft Frey (“NKF”) advised Brusa Elektronik, a Swiss based technology company in the field of development, manufacturing and distribution of power electronics used for battery electrical vehicles which has completed a carve-out transaction of
ACC Europe has announced the appointment of Maria Rocha Barros (pictured left) as the chapter’s new president. Maria succeeds Eva Argilés (pictured right), who has served with distinction
Schellenberg Wittmer: three new partners and a new counsel
Schellenberg Wittmer has further strengthened its team with the appointment of three new partners and a new counsel. On 1 September 2024, Dr Stéphanie Chuffart-Finsterwald joined the firm as a partner in Geneva. She will lead
EQT, advised by Bär & Karrer, together with its co-shareholders, has agreed to sell Open Systems to Swiss Post, advised by Walder Wyss. The transaction is subject to customary regulatory approval. Bär &
Neo Medical, a Swiss technology company specializing in spine surgery, has announced the successful completion of a strategic equity investment, including the conversion of existing shareholder loans. The financing round was led by Gyrus Capital,